We are live on ! Find out more
LP

LMR Partners Portfolio holdings

AUM $45.4B
1-Year Est. Return 60.68%
This Fund
S&P 500
This Quarter Est. Return
+23.27%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$11.9B
AUM Growth
-$665M
Cap. Flow
-$2.07B
Cap. Flow %
-17.42%
Top 10 Hldgs %
29.25%
Holding
1,790
New
534
Increased
200
Reduced
243
Closed
613

Top Sells

Rank Stock Value
1
TSM icon
TSMC
TSM
+$107M
2
GSK icon
GSK
GSK
+$58.9M
3
AVGO icon
Broadcom
AVGO
+$54M
4
UL icon
Unilever
UL
+$54M
5
MRVL icon
Marvell Technology
MRVL
+$48.3M

Sector Composition

Rank Sector Weight
1 Technology 11.5%
2 Communication Services 3.61%
3 Financials 3.6%
4 Healthcare 3.01%
5 Consumer Discretionary 1.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRTX icon
26
PUT
Vertex Pharmaceuticals
VRTX
$121B
$58.5M 0.49%
+145,200
New +$67.3M
CYBR
27
DELISTED
CyberArk
CYBR
$58M 0.49%
174,105
+125,000
+255% +$38M
GLW icon
28
Corning
GLW
$126B
$57M 0.48%
1,200,442
+700,442
+140% +$33.2M
NVDL icon
29
PUT
GraniteShares ETF Trust GraniteShares 2x Long NVDA Daily ETF
NVDL
$3.7B
$56.4M 0.47%
2,550,000
-600,000
-19% -$14.5M
SOXX icon
30
iShares Semiconductor ETF
SOXX
$44.2B
$56M 0.47%
260,000
+60,000
+30% +$13.4M
AMD icon
31
PUT
Advanced Micro Devices
AMD
$851B
$53.7M 0.45%
444,800
-354,100
-44% -$51M
HES
32
DELISTED
Hess
HES
$50.9M 0.43%
382,589
+129,000
+51% +$18M
AMED
33
PUT
DELISTED
Amedisys
AMED
$48.6M 0.41%
+535,800
New +$49.2M
MSI icon
34
Motorola Solutions
MSI
$69.4B
$48.6M 0.41%
105,152
+4,703
+5% +$2.23M
BA icon
35
Boeing
BA
$165B
$48.1M 0.4%
271,530
+234,662
+636% +$36.8M
IBN icon
36
ICICI Bank
IBN
$106B
$47.4M 0.4%
1,588,994
-893,709
-36% -$27M
TKO icon
37
CALL
TKO Group
TKO
$13.5B
$46.3M 0.39%
+325,700
New +$42.5M
SONY icon
38
Sony
SONY
$123B
$44.9M 0.38%
+2,119,760
New +$41.3M
LLY icon
39
CALL
Eli Lilly
LLY
$1.07T
$42.8M 0.36%
55,500
+10,500
+23% +$8.69M
GOOG icon
40
PUT
Alphabet (Google) Class C
GOOG
$3.9T
$42.7M 0.36%
224,000
-6,000
-3% -$1.06M
APH icon
41
Amphenol
APH
$188B
$42.1M 0.35%
606,297
+311,497
+106% +$21.8M
STLA icon
42
PUT
Stellantis
STLA
$16.5B
$41.7M 0.35%
3,201,000
-1,999,620
-38% -$26.5M
TER icon
43
Teradyne
TER
$54.8B
$41.3M 0.35%
328,378
+247,175
+304% +$29.3M
X
44
CALL
DELISTED
US Steel
X
$40.6M 0.34%
1,193,100
-127,500
-10% -$4.71M
JNPR
45
DELISTED
Juniper Networks
JNPR
$40.2M 0.34%
1,073,460
+428,993
+67% +$16.2M
ANSS
46
PUT
DELISTED
Ansys
ANSS
$40.2M 0.34%
119,100
-900
-0.8% -$302K
NCLH icon
47
PUT
Norwegian Cruise Line
NCLH
$8.89B
$38.2M 0.32%
1,485,100
VRTX icon
48
Vertex Pharmaceuticals
VRTX
$121B
$37.8M 0.32%
+93,801
New +$43.5M
TWLO icon
49
Twilio
TWLO
$29.1B
$37.4M 0.31%
346,082
-178,918
-34% -$16.4M
SLV icon
50
CALL
iShares Silver Trust
SLV
$28.1B
$37.3M 0.31%
1,415,500
+600,000
+74% +$17.1M

Similar funds

LMR Partners's Q4 2024 Portfolio in Review

As of Q4 2024, LMR Partners held 1,790 positions worth $11.9B, down 5.3% from $12.6B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

LMR Partners withdrew a net $2.07B in Q4 2024, closing 613 positions and reducing 243 holdings. Its most notable exit was Unilever, an estimated $54M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 10% a quarter earlier, followed by Communication Services and Financials.

Against the trend, LMR Partners opened a new position in Vertex Pharmaceuticals worth $37.8M.

  • LMR Partners's largest Q4 2024 buy was Vertex Pharmaceuticals: 93,801 shares worth $37.8M.
  • LMR Partners added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $472M increase.
  • LMR Partners's biggest Q4 2024 reduction was TSMC, cutting an estimated $107M.
  • LMR Partners fully exited Unilever in Q4 2024, selling an estimated $54M.
  • LMR Partners's ten largest holdings make up 29% of its $11.9B portfolio in Q4 2024.
  • LMR Partners opened 534 new positions and closed 613 in Q4 2024.
  • LMR Partners's portfolio value fell 5.3% quarter-over-quarter to $11.9B.

Based on LMR Partners's 13F filing for Q4 2024, filed 14 Feb 2025.